1. Home
  2. RPT vs NMRA Comparison

RPT vs NMRA Comparison

Compare RPT & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPT
  • NMRA
  • Stock Information
  • Founded
  • RPT 2014
  • NMRA 2019
  • Country
  • RPT United States
  • NMRA United States
  • Employees
  • RPT N/A
  • NMRA N/A
  • Industry
  • RPT
  • NMRA
  • Sector
  • RPT
  • NMRA
  • Exchange
  • RPT NYSE
  • NMRA Nasdaq
  • Market Cap
  • RPT 124.1M
  • NMRA 112.8M
  • IPO Year
  • RPT N/A
  • NMRA 2023
  • Fundamental
  • Price
  • RPT $2.75
  • NMRA $0.72
  • Analyst Decision
  • RPT Strong Buy
  • NMRA Buy
  • Analyst Count
  • RPT 1
  • NMRA 8
  • Target Price
  • RPT $4.00
  • NMRA $9.29
  • AVG Volume (30 Days)
  • RPT 112.3K
  • NMRA 846.2K
  • Earning Date
  • RPT 04-28-2025
  • NMRA 05-12-2025
  • Dividend Yield
  • RPT 8.79%
  • NMRA N/A
  • EPS Growth
  • RPT N/A
  • NMRA N/A
  • EPS
  • RPT N/A
  • NMRA N/A
  • Revenue
  • RPT N/A
  • NMRA N/A
  • Revenue This Year
  • RPT N/A
  • NMRA N/A
  • Revenue Next Year
  • RPT $19.21
  • NMRA N/A
  • P/E Ratio
  • RPT N/A
  • NMRA N/A
  • Revenue Growth
  • RPT N/A
  • NMRA N/A
  • 52 Week Low
  • RPT $2.29
  • NMRA $0.61
  • 52 Week High
  • RPT $3.86
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • RPT N/A
  • NMRA 46.83
  • Support Level
  • RPT N/A
  • NMRA $0.66
  • Resistance Level
  • RPT N/A
  • NMRA $0.73
  • Average True Range (ATR)
  • RPT 0.00
  • NMRA 0.06
  • MACD
  • RPT 0.00
  • NMRA 0.02
  • Stochastic Oscillator
  • RPT 0.00
  • NMRA 63.82

About RPT RITHM PROPERTY TRUST INC

Rithm Property Trust Inc is a real estate investment trust (REIT) externally managed by an affiliate of Rithm Capital Corp. (Rithm). The group is embarking on a new commercial real estate-focused investment. Its tailored approach to investment management seeks to generate attractive risk-adjusted returns for stockholders over the long term through dividends and capital appreciation.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: